Skip to main content

Table 1 Patient characteristics

From: Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma

Patient characteristics Values
Number 25
Gender
   Male 17 (68%)
   Female 8 (32%)
Age (years)
   Median, range 60 (34 to 74)
Localization
   Head 21
   Body and/or tail 4
Lymph node status
   Positive 16 (64%)
   Negative 9 (36%)
Grading
   G1 0
   G2 11
   G3 11
   G4 1
   Not reported 2a
RTX
EBRT median dose (range) (n = 26) 49.6 Gy (36 to 54 Gy) RT
IORT median dose (range) (n = 7) IORT: 12 Gy (10 to 15 Gy)
Concomitant CTX
   Overall (with gemcitabine) 23 (92%)
   None 2 (8%)
Toxicity
   Gastrointestinal (I to III°) 17
   Haematological (I° to IV°) 17
   Grade II 11
   Grade III 5
   Grade IV 1
Previous tumour resection None
Duration resection - onset of RT
   Median, range [days] 44 (12 to 100)
   <30 days 5
   30 to 50 days 11
   >50 days 9
  1. RT radiotherapy, Gy grey, IORT intraoperative radiotherapy, CTX chemotherapy, EBRT external beam radiotherapy. aExplanation in ‘Patients and methods’ section.